Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ja Min Byun

Showing results (111-120 of 123) with videos related to

Pageof 13
Sort By:
Frontiers in Oncology|December 12, 2022
A multicenter, open-label study for efficacy and safety evaluation of anagrelide in patients with treatment-naïve, high-risk essential thrombocythemia as a primary treatmentJa Min Byun, Ho Young Kim, Seung-Hyun Nam, et al.
Annals of Hematology|December 20, 2019
Clinical features and treatment outcomes of limited-stage mantle cell lymphoma: Consortium for Improving Survival of Lymphoma reportJae-Cheol Jo, Seok Jin Kim, Ho Sup Lee, et al.
Journal of Clinical Medicine|July 26, 2020
Optimizing Preparative Regimen for Umbilical Cord Blood Transplantation in Adult Acute Leukemia Patients: Acute Lymphoblastic Leukemia Requires Myeloablative Conditioning but Not Acute Myeloid LeukemiaJa Min Byun, Junshik Hong, Doyeun Oh, et al.
Nature Communications|March 30, 2024
Combination of acalabrutinib with lenalidomide and rituximab in relapsed/refractory aggressive B-cell non-Hodgkin lymphoma: a single-arm phase II trialChanghee Park, Ho Sup Lee, Ka-Won Kang, et al.
Blood|June 12, 2026
Anbalcabtagene autoleucel (PD-1 and TIGIT knockdown CD19 CAR-T) for relapsed/refractory large B-cell lymphoma (CRC01-01)Won Seog Kim, Seok Jin Kim, Dok Hyun Yoon, et al.
Blood Research|November 21, 2021
Multicenter retrospective analysis of patients with chronic lymphocytic leukemia in KoreaJun Ho Yi, Gyeong-Won Lee, Ji Hyun Lee, et al.
Clinical Lymphoma, Myeloma & Leukemia|July 6, 2025
Real-World Comparison of Carfilzomib, Lenalidomide, and Dexamethasone Versus Ixazomib, Lenalidomide, and Dexamethasone in Patients With Relapsed/Refractory Multiple Myeloma: KMM2004 StudyDo Young Kim, Chang-Ki Min, Hyeon-Seok Eom, et al.
Haematologica|June 11, 2026
The prognostic factors and immune microenvironment of primary plasma cell leukemia: the KMMWP-2204 studyMihee Kim, Ho Cheol Jang, Jae-Sook Ahn, et al.
Cancers|February 13, 2026
Second Salvage Autologous Hematopoietic Stem Cell Transplantation in Patients with Relapsed/Refractory Multiple Myeloma in the Era of Novel Agents: Results of the KMM2301 StudyJongheon Jung, Ji Hyun Lee, Sung-Hyun Kim, et al.
Annals of Hematology|May 28, 2016
Cytogenetic profiles of 2806 patients with acute myeloid leukemia-a retrospective multicenter nationwide studyJa Min Byun, Young Jin Kim, Hwi-Joong Yoon, et al.
Pageof 13

Showing results (111-120 of 123) with videos related to

Sort By:
Pageof 13
Frontiers in Oncology|December 12, 2022
A multicenter, open-label study for efficacy and safety evaluation of anagrelide in patients with treatment-naïve, high-risk essential thrombocythemia as a primary treatmentJa Min Byun, Ho Young Kim, Seung-Hyun Nam, et al.
Annals of Hematology|December 20, 2019
Clinical features and treatment outcomes of limited-stage mantle cell lymphoma: Consortium for Improving Survival of Lymphoma reportJae-Cheol Jo, Seok Jin Kim, Ho Sup Lee, et al.
Journal of Clinical Medicine|July 26, 2020
Optimizing Preparative Regimen for Umbilical Cord Blood Transplantation in Adult Acute Leukemia Patients: Acute Lymphoblastic Leukemia Requires Myeloablative Conditioning but Not Acute Myeloid LeukemiaJa Min Byun, Junshik Hong, Doyeun Oh, et al.
Nature Communications|March 30, 2024
Combination of acalabrutinib with lenalidomide and rituximab in relapsed/refractory aggressive B-cell non-Hodgkin lymphoma: a single-arm phase II trialChanghee Park, Ho Sup Lee, Ka-Won Kang, et al.
Blood|June 12, 2026
Anbalcabtagene autoleucel (PD-1 and TIGIT knockdown CD19 CAR-T) for relapsed/refractory large B-cell lymphoma (CRC01-01)Won Seog Kim, Seok Jin Kim, Dok Hyun Yoon, et al.
Blood Research|November 21, 2021
Multicenter retrospective analysis of patients with chronic lymphocytic leukemia in KoreaJun Ho Yi, Gyeong-Won Lee, Ji Hyun Lee, et al.
Clinical Lymphoma, Myeloma & Leukemia|July 6, 2025
Real-World Comparison of Carfilzomib, Lenalidomide, and Dexamethasone Versus Ixazomib, Lenalidomide, and Dexamethasone in Patients With Relapsed/Refractory Multiple Myeloma: KMM2004 StudyDo Young Kim, Chang-Ki Min, Hyeon-Seok Eom, et al.
Haematologica|June 11, 2026
The prognostic factors and immune microenvironment of primary plasma cell leukemia: the KMMWP-2204 studyMihee Kim, Ho Cheol Jang, Jae-Sook Ahn, et al.
Cancers|February 13, 2026
Second Salvage Autologous Hematopoietic Stem Cell Transplantation in Patients with Relapsed/Refractory Multiple Myeloma in the Era of Novel Agents: Results of the KMM2301 StudyJongheon Jung, Ji Hyun Lee, Sung-Hyun Kim, et al.
Annals of Hematology|May 28, 2016
Cytogenetic profiles of 2806 patients with acute myeloid leukemia-a retrospective multicenter nationwide studyJa Min Byun, Young Jin Kim, Hwi-Joong Yoon, et al.
Pageof 13